Sustained Benefit of Short-Term Levodopa Treatment on Inner Retinal Function in Patients With Diabetes
Retinal dysfunction and inner retinal structural changes could be potential biomarkers for preclinical DR, and L-DOPA treatment may provide sustained benefits for the diabetic retina.
Authors
- Machelle T. Pardue (ORCID: https://orcid.org/0000-0001-8738-6839)
- Andrew Feola (ORCID: https://orcid.org/0000-0002-7914-989X)
- Xiangqin Cui (ORCID: https://orcid.org/0000-0003-0621-9313)
- Dan Rubenstein (ORCID: https://orcid.org/0000-0002-3747-9946)
- Mary K. Rhee (ORCID: https://orcid.org/0000-0002-0747-1476)
- Rishi Patel (ORCID: https://orcid.org/0000-0002-2797-4206)
- F. C. Moore
- Andrew Hendrick (ORCID: https://orcid.org/0000-0003-3322-9349)
- Stephen Phillips (ORCID: https://orcid.org/0000-0002-7901-0839)
- Xiaxian Ou
- Charles W. Young
- Caleigh Cullinan
Institutions
- Georgia Institute of Technology (US)
- Emory University (US)
- Atlanta VA Health Care System (US)
Publication Details
- Journal
- Translational Vision Science & Technology
- Published
- 2025-09-02
- DOI
- https://doi.org/10.1167/tvst.14.9.5
- Citations
- 1
- Primary Topic
- Retinal Development and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.81
Funders
- U.S. Department of Veterans Affairs
- Research to Prevent Blindness
- Emory University